EchoStar insider exercises options and sells shares
EchoStar CORP director and officer Hamid Akhavan reported a mix of option exercises and share sales in Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EchoStar CORP director and officer Hamid Akhavan reported a mix of option exercises and share sales in Class A Common Stock. On June 5, 2026, he exercised a total of 142,917 employee stock options at $14.04 per share, receiving the same number of shares. That day he also completed open-market sales totaling 52,586 shares at $121.00 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he holds 910,706 shares directly and 364 shares indirectly through a 401(k) plan.
Insights
Akhavan executes options and sells shares under a 10b5-1 plan, with sizable holdings remaining.
Hamid Akhavan, a director and CEO of EchoStar Capital, exercised 142,917 employee stock options at $14.04 per share into Class A Common Stock, then sold 52,586 shares at $121.00 per share in open-market trades on June 5, 2026.
The filing notes the trades were made under a Rule 10b5-1 trading plan adopted on March 6, 2026, indicating they were pre-scheduled rather than opportunistic. Following the net-sell activity, he still directly holds 910,706 shares and indirectly holds 364 shares via a 401(k) plan.
This pattern reflects an exercise-and-sell sequence that monetizes part of his equity while maintaining a substantial ownership position. With the derivativeSummary showing no remaining options from these grants, the reported options were fully exercised, and subsequent company filings will show any new awards or additional plan activity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 122,500 | $14.04 | $1.72M |
| Exercise | Employee Stock Option (Right to Buy) | 20,417 | $14.04 | $287K |
| Exercise | Class A Common Stock | 122,500 | $14.04 | $1.72M |
| Sale | Class A Common Stock | 45,073 | $121.00 | $5.45M |
| Exercise | Class A Common Stock | 20,417 | $14.04 | $287K |
| Sale | Class A Common Stock | 7,513 | $121.00 | $909K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (4)
- F1. The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- F2. By 401(K).
- F3. 40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026.
- F4. The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Employee Stock Option (Right to Buy) financial
Class A Common Stock financial
open-market sale financial
derivative exercise/conversion financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did EchoStar (SATS) director Hamid Akhavan report in this Form 4?
How many EchoStar (SATS) stock options did Akhavan exercise?
What types of securities are involved in Akhavan’s EchoStar (SATS) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.